D'Amico TA - Search Results

1

Outcomes of video-assisted thoracoscopic decortication.

Tong BC, Hanna J, Toloza EM, Onaitis MW, D'Amico TA, Harpole DH, Burfeind WR. Tong BC, et al. Ann Thorac Surg. 2010 Jan;89(1):220-5. doi: 10.1016/j.athoracsur.2009.09.021. Ann Thorac Surg. 2010. PMID: 20103240

2

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr. D'Amico TA, et al. J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43. doi: 10.1016/s0022-5223(99)70294-1. J Thorac Cardiovasc Surg. 1999. PMID: 10096969 Free article.

3

Malignant melanoma presenting as a mediastinal mass.

Lau CL, Bentley RC, Gockerman JP, Que LG, D'Amico TA. Lau CL, et al. Ann Thorac Surg. 1999 Mar;67(3):851-2. doi: 10.1016/s0003-4975(99)00075-2. Ann Thorac Surg. 1999. PMID: 10215250

4

Cognitive decline after major noncardiac operations: a preliminary prospective study.

Grichnik KP, Ijsselmuiden AJ, D'Amico TA, Harpole DH Jr, White WD, Blumenthal JA, Newman MF. Grichnik KP, et al. Ann Thorac Surg. 1999 Nov;68(5):1786-91. doi: 10.1016/s0003-4975(99)00992-3. Ann Thorac Surg. 1999. PMID: 10585059

5

Molecular biologic substaging of stage I lung cancer according to gender and histology.

D'Amico TA, Aloia TA, Moore MB, Herndon JE 2nd, Brooks KR, Lau CL, Harpole DH Jr. D'Amico TA, et al. Ann Thorac Surg. 2000 Mar;69(3):882-6. doi: 10.1016/s0003-4975(99)01522-2. Ann Thorac Surg. 2000. PMID: 10750777

6

Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients.

Lau CL, Palmer SM, Posther KE, Howell DN, Reinsmoen NL, Massey HT, Tapson VF, Jaggers JJ, D'Amico TA, Davis RD Jr. Lau CL, et al. Ann Thorac Surg. 2000 May;69(5):1520-4. doi: 10.1016/s0003-4975(00)01224-8. Ann Thorac Surg. 2000. PMID: 10881834

7

Molecular biology of esophageal cancer.

D'Amico TA, Harpole DH Jr. D'Amico TA, et al. Chest Surg Clin N Am. 2000 Aug;10(3):451-69. Chest Surg Clin N Am. 2000. PMID: 10967750 Review.

8

The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.

Harpole DH Jr, Moore MB, Herndon JE 2nd, Aloia T, D'Amico TA, Sporn T, Parr A, Linoila I, Allegra C. Harpole DH Jr, et al. Clin Cancer Res. 2001 Mar;7(3):562-9. Clin Cancer Res. 2001. PMID: 11297249

9

Tumor marker expression is predictive of survival in patients with esophageal cancer.

Aloia TA, Harpole DH Jr, Reed CE, Allegra C, Moore MB, Herndon JE 2nd, D'Amico TA. Aloia TA, et al. Ann Thorac Surg. 2001 Sep;72(3):859-66. doi: 10.1016/s0003-4975(01)02838-7. Ann Thorac Surg. 2001. PMID: 11565671

10

Predicting the sites of metastases from lung cancer using molecular biologic markers.

D'Amico TA, Aloia TA, Moore MB, Conlon DH, Herndon JE 2nd, Kinch MS, Harpole DH Jr. D'Amico TA, et al. Ann Thorac Surg. 2001 Oct;72(4):1144-8. doi: 10.1016/s0003-4975(01)02979-4. Ann Thorac Surg. 2001. PMID: 11603427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

443 results

Search Page